Ian D. Dang

Array ( [id] => 4553558 [patent_doc_number] => 07837999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Method of increasing muscle mass with IGF-1 fusion polypeptides' [patent_app_type] => utility [patent_app_number] => 12/134301 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9971 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/837/07837999.pdf [firstpage_image] =>[orig_patent_app_number] => 12134301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797079 [patent_doc_number] => 08435946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form' [patent_app_type] => utility [patent_app_number] => 12/132642 [patent_app_country] => US [patent_app_date] => 2008-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5140 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12132642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511374 [patent_doc_number] => 20110257084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'EXENDIN DERIVATIVE LINKED BIOTIN, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/919399 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6241 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257084.pdf [firstpage_image] =>[orig_patent_app_number] => 12919399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820426 [patent_doc_number] => 20080226631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'METHODS OF MODULATING CYTOKINE ACTIVITY; RELATED REAGENTS' [patent_app_type] => utility [patent_app_number] => 12/119261 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12611 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226631.pdf [firstpage_image] =>[orig_patent_app_number] => 12119261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309708 [patent_doc_number] => 20090016989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'ANTIBODIES TO HUMAN SOMATOSTATIN RECEPTOR AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/109742 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23585 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20090016989.pdf [firstpage_image] =>[orig_patent_app_number] => 12109742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435222 [patent_doc_number] => 08282990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Method for preparing a biodegradable polymer microsphere containing a glucose-regulating peptide' [patent_app_type] => utility [patent_app_number] => 12/595434 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6338 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12595434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676808 [patent_doc_number] => 20080214439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'AMINO ACID SUBSTITUTED MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/105155 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 63499 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214439.pdf [firstpage_image] =>[orig_patent_app_number] => 12105155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873907 [patent_doc_number] => 20080200641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'AMINO ACID SUBSTITUTED MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/105154 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 63493 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200641.pdf [firstpage_image] =>[orig_patent_app_number] => 12105154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4522361 [patent_doc_number] => 07951551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Kits and reagents for luciferase detection assay system' [patent_app_type] => utility [patent_app_number] => 12/099616 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10208 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951551.pdf [firstpage_image] =>[orig_patent_app_number] => 12099616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276851 [patent_doc_number] => 20100256332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => ' GLP-1 Fusion Peptides, Their Production and Use' [patent_app_type] => utility [patent_app_number] => 12/531411 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20018 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256332.pdf [firstpage_image] =>[orig_patent_app_number] => 12531411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988325 [patent_doc_number] => 08076458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Anti-claudin-4 antibody' [patent_app_type] => utility [patent_app_number] => 12/049581 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 41969 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076458.pdf [firstpage_image] =>[orig_patent_app_number] => 12049581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718625 [patent_doc_number] => 20080241147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Ph INTERACTING PROTEIN AND USE TO DIAGNOSE AND TREAT CANCER' [patent_app_type] => utility [patent_app_number] => 12/046953 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 32158 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241147.pdf [firstpage_image] =>[orig_patent_app_number] => 12046953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020443 [patent_doc_number] => 08530428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Treating cancer with granulocyte-macrophage colony stimulating factor' [patent_app_type] => utility [patent_app_number] => 12/529897 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3970 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12529897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 71283 [patent_doc_number] => 07754440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'High-throughput screen for identifying selective persistent sodium channels channel blockers' [patent_app_type] => utility [patent_app_number] => 12/041739 [patent_app_country] => US [patent_app_date] => 2008-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 26 [patent_no_of_words] => 21968 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754440.pdf [firstpage_image] =>[orig_patent_app_number] => 12041739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102233 [patent_doc_number] => 07723053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'High-throughput screen for identifying selective persistent sodium channels channel blockers' [patent_app_type] => utility [patent_app_number] => 12/041726 [patent_app_country] => US [patent_app_date] => 2008-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 26 [patent_no_of_words] => 21970 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723053.pdf [firstpage_image] =>[orig_patent_app_number] => 12041726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6371291 [patent_doc_number] => 20100075337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'METHOD OF IDENTIFICATION OF CELLS THAT SHOW SENSITIVITY TO MODULATION OF SIGNALINGH MEDIATED BY FIBROBLAST GROWTH FACTOR RECEPTOR OR A VARIANT THEREOF' [patent_app_type] => utility [patent_app_number] => 12/527470 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16806 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075337.pdf [firstpage_image] =>[orig_patent_app_number] => 12527470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13688 [patent_doc_number] => 07807643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Compositions containing leptin' [patent_app_type] => utility [patent_app_number] => 12/034419 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6332 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807643.pdf [firstpage_image] =>[orig_patent_app_number] => 12034419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495216 [patent_doc_number] => 20100286055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'USE OF WNT3A FOR ACCELERATION OF WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 12/527185 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15227 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286055.pdf [firstpage_image] =>[orig_patent_app_number] => 12527185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 201977 [patent_doc_number] => 07632503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Method of treating a muscle-related condition with modified IGF1 polypeptides' [patent_app_type] => utility [patent_app_number] => 12/070213 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11745 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632503.pdf [firstpage_image] =>[orig_patent_app_number] => 12070213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785013 [patent_doc_number] => 20080138342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Methods of treating pre-eclampsia and eclampsia' [patent_app_type] => utility [patent_app_number] => 12/069757 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 30456 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138342.pdf [firstpage_image] =>[orig_patent_app_number] => 12069757 [rel_patent_id] =>[rel_patent_doc_number] =>)